Hands signing a legal document on a clipboard beside a judge's gavel on wooden table.

Fayetteville Dangerous Drug & Defective Medication Attorneys

Serving Fayetteville, Washington County, and Northwest Arkansas

TIME-SENSITIVE: The Arkansas statute of limitations for dangerous drug product liability claims is generally THREE (3) YEARS from the date of injury or discovery. Missing this deadline permanently bars your claim, regardless of how serious your injuries are. Call today for a free case evaluation.

Pharmaceutical Companies Have a Legal Duty to Fayetteville Patients — When They Fail, You Have Rights

Drug manufacturers conduct clinical trials, analyze safety data, review adverse event reports, and make deliberate business decisions about which risks to disclose to patients and physicians. When those decisions favor profit margins over patient safety — when known risks are buried, minimized, or omitted from labeling — Arkansas law holds them accountable.

Arkansas product liability law (Ark. Code Ann. § 16-116-202 et seq.) allows injured patients to pursue claims against manufacturers, distributors, and others in the drug’s chain of distribution. A drug does not need to be recalled to support a valid claim. The absence of a recall does not mean the drug was safe or that your injury was acceptable.

Most dangerous drug cases proceed as mass torts — not class actions. This is an important distinction: in a mass tort, your individual damages are assessed separately. You are not dividing a fixed pool of money with thousands of other plaintiffs. What the drug actually did to you — your specific medical bills, your lost income, your suffering — determines your recovery.

Our Northwest Arkansas team handles these cases on full contingency. We advance all litigation costs. You pay no attorney fee unless and until we recover compensation for you. If we do not win your case, you owe us nothing for attorney fees. [Insert whether client is responsible for costs if no recovery — confirm with your fee agreement before publishing.]

Do You Qualify? Current Dangerous Drug Cases We Are Evaluating

If you took any of the following medications and suffered a serious injury, you may have a compensable claim. Call us to find out if you qualify — the evaluation is free and confidential.

GLP-1 Agonists — Ozempic / Wegovy / Mounjaro / Semaglutide

Qualifying injuries: Gastroparesis (stomach paralysis), bowel obstruction, intestinal ileus, severe nausea/vomiting requiring hospitalization. Cases pending in federal court. Who qualifies: patients prescribed these drugs for weight loss or diabetes who developed serious GI complications.

SSRI Antidepressants — Zoloft, Paxil, Prozac, Lexapro (Prenatal Exposure)

Qualifying injuries: Congenital heart defects, persistent pulmonary hypertension of the newborn (PPHN), and other birth defects in children born to mothers who took SSRIs during pregnancy. Who qualifies: mothers who used these drugs during pregnancy whose child was born with cardiac or other serious birth defects.

Blood Thinners — Xarelto / Eliquis / Pradaxa

Qualifying injuries: Uncontrollable internal bleeding, GI hemorrhage, brain bleed, and death — particularly where no reversal agent was available. Who qualifies: patients prescribed newer anticoagulants who suffered serious uncontrolled bleeding events not related to known contraindications.

Acetaminophen / Tylenol — Prenatal Exposure (Autism/ADHD)

Qualifying injuries: Children diagnosed with autism spectrum disorder or ADHD whose mothers used acetaminophen regularly during pregnancy. Active federal MDL proceedings. Who qualifies: families with a child diagnosed with ASD or ADHD with documented prenatal acetaminophen exposure.

Fluoroquinolone Antibiotics — Cipro / Levaquin / Avelox

Qualifying injuries: Tendon rupture (especially Achilles), peripheral neuropathy, aortic aneurysm or dissection, and permanent nerve damage. Who qualifies: patients who took fluoroquinolone antibiotics and developed tendon, nerve, or aortic complications — particularly when safer alternatives were available.

Proton Pump Inhibitors — Prilosec / Nexium / Prevacid / Protonix (Long-Term Use)

Qualifying injuries: Chronic kidney disease, acute kidney injury, bone fractures from mineral depletion, and hypomagnesemia. Who qualifies: patients on long-term PPI therapy who developed kidney disease or serious fractures not explained by other conditions.

Depo-Provera (Medroxyprogesterone Acetate) — Brain Tumor Claims

Qualifying injuries: Meningioma (intracranial brain tumor) diagnosed after extended use of injectable contraceptive. FIRST TRIAL SCHEDULED: December 2026. Who qualifies: women who received Depo-Provera injections for 2+ years and were later diagnosed with a meningioma brain tumor.

Hair Relaxer / Chemical Straightening Products

Qualifying injuries: Uterine cancer, endometrial cancer, and other hormone-sensitive cancers. Active federal MDL. Who qualifies: women who used chemical hair relaxer products regularly over multiple years and were subsequently diagnosed with uterine or endometrial cancer.

CPAP Machines — Philips Respironics (Sound Abatement Foam)

Qualifying injuries: Cancer (lung, trachea, nose, throat), respiratory harm, and organ toxicity from chemical off-gassing of degraded polyester-based polyurethane foam. Who qualifies: patients who used affected Philips CPAP/BiPAP/ventilator devices before recall and received a cancer or chronic respiratory diagnosis.

Other Prescription or OTC Drug Injuries

If a prescription or over-the-counter medication caused you serious, unexpected harm — call us. We evaluate all pharmaceutical injury cases free of charge. If you have questions about a drug not listed here, we will tell you honestly whether we believe a viable claim exists.

Three Legal Theories — How These Cases Are Won

Defective Design

The drug’s formulation or delivery mechanism was inherently dangerous — it caused harm even when manufactured correctly and used as the manufacturer intended. The manufacturer chose a design that created unreasonable risk.

Failure to Warn

The manufacturer knew of serious risks — through its own clinical data, adverse event databases, or post-market surveillance — but failed to disclose those risks adequately in package labeling, prescribing information, or physician communications. This is the most common and often strongest theory in pharmaceutical litigation.

Manufacturing Defect

A specific batch, lot, or production run was contaminated, mislabeled, or otherwise incorrectly manufactured — deviating from the drug’s intended design and causing individual patient harm.

Arkansas Law — What Fayetteville Patients Must Know

Statute of Limitations — Ark. Code Ann. § 16-116-203: Three (3) years from the date of injury or the date you knew or reasonably should have known that the drug caused your harm. This deadline is strictly enforced by Arkansas courts. Failing to file before it expires almost certainly ends your legal right to compensation permanently.

Discovery Rule: For slowly developing injuries — kidney disease, cancer, neurological damage — the three-year clock begins when you discovered, or should have discovered, the drug-injury connection. This must be analyzed case by case by an attorney. Do not assume your claim is time-barred without consulting a lawyer.

Mass Tort vs. Class Action: In a mass tort, your individual damages are assessed based on what the drug did specifically to you. Your recovery is not divided equally among thousands. This structure benefits seriously injured plaintiffs significantly compared to a class action.

Modified Comparative Fault — Ark. Code Ann. § 16-64-122: Arkansas patients can recover if they are less than 50% at fault for their own injury, with damages reduced proportionally. In drug defect cases, comparative fault arguments against patients following a physician’s prescription are rarely successful for manufacturers.

No Economic Loss Rule Barrier: Arkansas does not follow the economic loss rule in product liability cases, allowing broader recovery than some other states.

Wrongful Death — Ark. Code § 16-62-102: If a dangerous drug caused a loved one’s death, Arkansas law allows the estate to file a wrongful death action within three years of death. Recoverable damages include medical costs, funeral expenses, lost financial support, and loss of companionship.

What Compensation May Be Available

All medical expenses caused by the drug — past and future — including hospitalization, specialist care, surgery, and ongoing treatment

Lost wages during recovery and, for permanent disability, diminished future earning capacity

Pain and suffering, emotional distress, and loss of enjoyment of life

Permanent disability, disfigurement, or chronic health impairment caused by the drug’s side effects

Wrongful death damages if a dangerous drug caused a family member’s death

Punitive damages where a manufacturer concealed known risks or acted with reckless disregard for patient safety

Frequently Asked Questions — Dangerous Drug & Medication Lawsuits

Call us. The list of drugs currently subject to active mass tort litigation changes frequently as new safety data emerges, MDLs are formed, and older cases resolve. The drugs listed on this page are those with active federal proceedings as of June 2026, but many other medications may support claims. If you suffered a serious, unexpected injury while taking a prescription or OTC drug, tell us the drug name, your diagnosis, and your treatment history — we will evaluate it at no cost.

Yes. An FDA recall is not required to bring a product liability lawsuit. Recalls often occur years after widespread patient harm, if at all. The legal question is not whether the FDA acted — it is whether the drug was defective in its design, manufacturing, or labeling, and whether that defect caused your injury. Many of the largest pharmaceutical settlements in history involved drugs that were never recalled.

No. A physician’s good-faith prescription does not insulate the manufacturer from liability. Drug manufacturers have an independent legal duty to disclose all known risks to prescribers through accurate labeling, package inserts, and ‘Dear Doctor’ communications. If the manufacturer failed to warn your doctor of known risks, and your doctor prescribed the drug without that information, the manufacturer — not your doctor — is responsible for that failure. In many cases, claims against both the manufacturer and the physician can coexist, though they are legally distinct.

Not necessarily. Arkansas’s discovery rule allows the three-year statute of limitations to begin running from when you discovered — or reasonably should have discovered — the connection between the drug and your injury. For slowly developing conditions like cancer, kidney disease, or neurological damage, that clock may not have started when you first took the drug. Do not assume your claim is time-barred without speaking to an attorney. We evaluate this question as part of your free case review.

In a class action, all plaintiffs receive the same or proportionally equal recovery from a shared settlement pool. In a mass tort, each plaintiff’s damages are assessed individually based on the specific harm they suffered — their medical bills, their lost income, their particular suffering. Most pharmaceutical injury cases proceed as mass torts, which generally results in meaningfully larger individual recoveries for seriously injured plaintiffs. Your compensation reflects what the drug specifically did to you, not what it did to the average plaintiff.

That is a medical question, not a legal one — and the answer depends entirely on your medical situation. Do not stop any prescribed medication without consulting your prescribing physician first. What we can tell you is that continuing to take a medication does not automatically bar a legal claim, and stopping it does not create one. Your health comes first. Once you have spoken with your doctor, call us to evaluate whether a legal claim exists.

Yes. The fact that a drug provided therapeutic benefit before causing harm does not eliminate a manufacturer’s liability for failing to warn of risks that led to that harm. The legal question is not whether the drug had benefits — it is whether the manufacturer disclosed all known risks so you and your physician could make an informed decision. If risks were concealed or minimized, the benefit you received earlier does not bar your claim.

Yes. Arkansas wrongful death law (Ark. Code § 16-62-102) allows the deceased patient’s estate — typically filed by a surviving spouse, parent, or adult child — to pursue a claim for the death caused by a defective or dangerous drug. The statute of limitations for wrongful death is generally three years from the date of death. Recoverable damages may include medical expenses, funeral costs, the deceased’s lost future income, and loss of companionship. Contact us immediately — these deadlines are strictly enforced.

Most mass tort pharmaceutical cases resolve through settlement without a trial. That said, some cases do proceed to trial, and we prepare every client for that possibility. Whether you would need to testify depends on how your case develops. We guide every client through what to expect at each stage, and we will never push you toward a resolution that isn’t in your best interest simply to avoid litigation.

Pharmaceutical mass tort cases typically take longer than standard personal injury cases — often two to five years from filing to resolution, and sometimes longer in early-stage MDLs. Factors include the maturity of the MDL, the strength of your individual case, the volume of litigation, and whether bellwether trials produce results that motivate settlement. We will give you an honest assessment of timing for your specific claim during your free consultation.

⚠ LEGAL NOTICE: FAQ responses provide general legal information only and do not constitute legal advice. Individual case outcomes depend on specific facts and timing. No attorney-client relationship is formed by reading these questions and answers. Contact a licensed Arkansas attorney immediately to evaluate your claim before any statute of limitations expires.

⚠ LEGAL NOTICE: This content provides general legal information only. It does not constitute legal advice and does not create an attorney-client relationship. Every drug injury claim is fact-specific and time-sensitive. The Arkansas statute of limitations is strictly enforced. No representation is made that results similar to those in other cases will be obtained. Contact a licensed Arkansas attorney immediately before any deadline expires.

REQUIRED ADVERTISING DISCLOSURES — ARKANSAS RULES OF PROFESSIONAL CONDUCT

Attorney Advertising. Edward O. Moody, P.A., 801 West Fourth Street, Little Rock, Arkansas 72201 | Responsible Attorney: Edward O. Moody, Licensed in Arkansas | This communication is an advertisement. Prior results do not guarantee a similar outcome. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. Contingency fee representation: if no recovery is obtained, the client [will / will not — choose one and confirm with your fee agreement] be responsible for costs advanced. This content provides general legal information only and does not constitute legal advice. No attorney-client relationship is formed by reading this content or submitting a contact form. © 2026 Edward O. Moody, P.A. All rights reserved. Records of this advertisement will be retained for five (5) years per Ark. R. Prof. Conduct 7.2.